Synergistic enhancement of human bone marrow stromal cell proliferation and osteogenic differentiation on BMP-2-derived and RGD peptide concentration gradients

Acta Biomaterialia

Volumn 7, Issue 5, 2011, Pages 2091-2100

  Moore, Nicole M ^a   Lin, Nancy J ^a   Gallant, Nathan D ^a,c   Becker, Matthew L ^b  

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^b The University of Akron   (United States)

^c University of South Florida   (United States)

Author keywords

Bioactive gradients; BMP 2; Cell proliferation; Click chemistry; RGD

Indexed keywords

BONE; PEPTIDES; SCAFFOLDS (BIOLOGY); SELF ASSEMBLED MONOLAYERS; TISSUE REGENERATION;

BIOACTIVE GRADIENT; BIOACTIVES; BONE MORPHOGENIC PROTEIN; BONE MORPHOGENIC PROTEIN-2; CLICK CHEMISTRY; CONCENTRATION-DEPENDENT; EXTRACELLULAR MATRIX PROTEIN; HUMAN BONE MARROW STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; RGD;

CELL PROLIFERATION;

BONE MORPHOGENETIC PROTEIN; BONE SIALOPROTEIN; CARBOXYL GROUP; GROWTH FACTOR; MESSENGER RNA; SCAFFOLD PROTEIN; SCLEROPROTEIN; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; CELL PROLIFERATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; TISSUE ENGINEERING; UPREGULATION;

EID: 79953896000     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.01.019     Document Type: Article

References (59)

1. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994;56:283-94. (Pubitemid 24360045)
2. Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tiss Res 1988;254:317-30.
3. Chaudhary LR, Hofmeister AM, Hruska KA. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 2004;34(3):401-20.
4. Moursi AM, Damsky CH, Lull J, Zimmerman D, Doty SB, Aota S, et al. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 1996;109(6):1369-80. (Pubitemid 26190487)
5. Ruoslahti E, Pierschbacher MD. Arg - Gly - Asp: a versatile cell recognition signal. Cell 1986;44:517-8.
6. Liu SQ, Ee PL, Ke CY, Hedrick JL, Yang YY. Biodegradable poly(ethylene glycol) - peptide hydrogels with well-defined structure and properties for cell delivery. Biomaterials 2009;30:1453-61.
7. Ho MH, Hou LT, Tu CY, Hsieh HJ, Lai JY, Chen WJ, et al. Promotion of cell affinity of porous PLLA scaffolds by immobilization of RGD peptides via plasma treatment. Macromol Biosci 2006;6:90-8.
8. Ho MH, Wang DM, Hsieh HJ, Liu HC, Hsien TY, Lai JY, et al. Preparation and characterization of RGD-immobilized chitosan scaffolds. Biomaterials 2005;26:3197-206.
9. Hsiong SX, Boontheekul T, Huebsch N, Mooney DJ. Cyclic arginine - glycine - aspartate peptides enhance three-dimensional stem cell osteogenic differentiation. Tissue Eng Part A 2009;15:263-72.
10. Comisar WA, Kazmers NH, Mooney DJ, Linderman JJ. Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: a combined computational and experimental approach. Biomaterials 2007;28:4409-17. (Pubitemid 47214638)
11. Deng C, Tian H, Zhang P, Sun J, Chen X, Jing X. Synthesis and characterization of RGD peptide grafted poly(ethylene glycol)-b-poly(L-lactide)- b-poly(L-glutamic acid) triblock copolymer. Biomacromolecules 2006;7:590-6.
12. Santiago LY, Nowak RW, Peter Rubin J, Marra KG. Peptide-surface modification of poly(caprolactone) with laminin-derived sequences for adipose-derived stem cell applications. Biomaterials 2006;27:2962-9. (Pubitemid 43208921)
13. Zimmerman D, Jin F, Leboy P, Hardy S, Damsky C. Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts. Dev Biol 2000;220:2-15. (Pubitemid 30181014)
14. Takeuchi Y, Suzawa M, Kikuchi T, Nishida E, Fujita T, Matsumoto T. Differentiation and transforming growth factor-beta receptor downregulation by collagen - alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem 1997;272:29309-16. (Pubitemid 27498224)
15. Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 1998;273:32988-94. (Pubitemid 28557693)
16. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87:9843-7. (Pubitemid 120016540)
17. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000;20:8783-92. (Pubitemid 32245911)
18. Murakami N, Saito N, Takahashi J, Ota H, Horiuchi H, Nawata M, et al. Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 2003;24:2153-9. (Pubitemid 36434033)
19. Takahashi Y, Yamamoto M, Tabata Y. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and [beta]-tricalcium phosphate. Biomaterials 2005;26:4856-65. (Pubitemid 40343033)
20. Hollinger JO, Schmitt JM, Buck DC, Shannon R, Joh SP, Zegzula HD, et al. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res 1998;43:356-64. (Pubitemid 28544095)
21. Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998;16:247-52.
22. Groeneveld EH, Burger EH. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrin 2000;142:9-21. (Pubitemid 30094193)
23. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87:2220-4.
24. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 1999;46:193-202.
25. Lutolf MP, Weber FE, Schmoekel HG, Schense JC, Kohler T, Muller R, et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotech 2003;21:513-8. (Pubitemid 36532015)
26. Saito A, Suzuki Y, Ogata S, Ohtsuki C, Tanihara M. Accelerated bone repair with the use of a synthetic BMP-2-derived peptide and bone-marrow stromal cells. J Biomed Mater Res 2005;72:77-82. (Pubitemid 39628335)
27. Saito A, Suzuki Y, Ogata S, Ohtsuki C, Tanihara M. Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. Biochim Biophys Acta 2003;1651:60-7. (Pubitemid 38234553)
28. Saito A, Suzuki Y, Ogata S, Ohtsuki C, Tanihara M. Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide. J Biomed Mater Res 2004;70:115-21. (Pubitemid 38849818)
29. He X, Ma J, Jabbari E. Effect of grafting RGD and BMP-2 protein-derived peptides to a hydrogel substrate on osteogenic differentiation of marrow stromal cells. Langmuir 2008;24:12508-16.
30. Gallant ND, Lavery KA, Amis EJ, Becker ML. Universal gradient substrates for "click" biofunctionalization. Adv Mater 2007;19:965-9.
31. Moore NM, Lin NJ, Gallant ND, Becker ML. The use of immobilized osteogenic growth peptide on gradient substrates synthesized via click chemistry to enhance MC3T3-E1 osteoblast proliferation. Biomaterials 2010;31:1604-11.
32. Acharya AP, Dolgova NV, Moore NM, Xia CQ, Clare-Salzler MJ, Becker ML, et al. The modulation of dendritic cell integrin binding and activation by RGD peptide density gradient substrates. Biomaterials 2010;31:7444-54.
33. Hawker CJ, Wooley KL. The convergence of synthetic organic and polymer chemistries. Science 2005;309(5738):1200-5. (Pubitemid 41170906)
34. Shi Q, Chen X, Lu T, Jing X. The immobilization of proteins on biodegradable polymer fibers via click chemistry. Biomaterials 2008;29:1118-26. (Pubitemid 350296317)
35. O'Reilly RK, Joralemon MJ, Hawker CJ, Wooley KL. Facile syntheses of surface-functionalized micelles and shell cross-linked nanoparticles. J Polym Sci A: Polym Chem 2006;44:5203-17.
36. Parrish B, Breitenkamp RB, Emrick T. PEG- and peptide-grafted aliphatic polyesters by click chemistry. J Am Chem Soc 2005;127:7404-10. (Pubitemid 40746025)
37. Roberson SV, Fahey AJ, Sehgal A, Karim A. Multifunctional ToF-SIMS: combinatorial mapping of gradient energy substrates. Appl Surf Sci 2002;200:150-64.
38. Berry BC, Stafford CM, Pandya M, Lucas LA, Karim A, Fasolka MJ. Versatile platform for creating gradient combinatorial libraries via modulated light exposure. Rev Sci Instrum 2007;78:6.
39. Fadeev AY, McCarthy TJ. Trialkylsilane monolayers covalently attached to silicon surfaces: wettability studies indicating that molecular topography contributes to contact angle hysteresis. Langmuir 1999;15:3759-66.
40. Bailey LO, Washburn NR, Simon Jr CG, Chan ES, Wang FW. Quantification of inflammatory cellular responses using real-time polymerase chain reaction. J Biomed Mater Res 2004;69:305-13. (Pubitemid 38478823)
41. Franceschi RT, Xiao G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 2003;88:446-54. (Pubitemid 36158266)
42. Massia SP, Hubbell JA. An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J Cell Biol 1991;114:1089-100. (Pubitemid 21909870)
43. Humphries MJ, Akiyama SK, Komoriya A, Olden K, Yamada KM. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J Cell Biol 1986;103:2637-47. (Pubitemid 17008010)
44. Karageorgiou V, Meinel L, Hofmann S, Malhotra A, Volloch V, Kaplan DL. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res 2004;71:528-37. (Pubitemid 39489907)
45. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 1992;7:683-92.
46. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997;36:17-28. (Pubitemid 27270994)
47. Bitar M, Brown RA, Salih V, Kidane AG, Knowles JC, Nazhat SN. Effect of cell density on osteoblastic differentiation and matrix degradation of biomimetic dense collagen scaffolds. Biomacromolecules 2008;9:129-35. (Pubitemid 351201590)
48. Toh YC, Ho ST, Zhou Y, Hutmacher DW, Yu H. Application of a polyelectrolyte complex coacervation method to improve seeding efficiency of bone marrow stromal cells in a 3D culture system. Biomaterials 2005;26:4149-60. (Pubitemid 40138661)
49. Kim K, Dean D, Mikos AG, Fisher JP. Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromolecules 2009;10(7):1810-7.
50. Kazuhito S, Paul K, Paolo B, Pamela Gehron R. Osteogenic imprinting upstream of marrow stromal cell differentiation. J Cell Biochem 2000;78(3):391-403.
51. Frank O, Heim M, Jakob M, Barbero A, Schafer D, Bendik I, et al. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem 2002;85:737-46. (Pubitemid 34462784)
52. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747-54. (Pubitemid 27516177)
53. Bianco P, Riminucci M, Bonucci E, Termine JD, Robey PG. Bone sialoprotein (BSP) secretion and osteoblast differentiation: relationship to bromodeoxyuridine incorporation, alkaline phosphatase, and matrix deposition. J Histochem Cytochem 1993;41:183-91. (Pubitemid 23039097)
54. Baker JC, Harland RM. From receptor to nucleus: the SMAD pathway. Cur Opin Gen Dev 1997;7:467-73. (Pubitemid 27404276)
55. Benoit DS, Schwartz MP, Durney AR, Anseth KS. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater 2008;7:816-23.
56. Phillips JE, Petrie TA, Creighton FP, Garcia AJ. Human mesenchymal stem cell differentiation on self-assembled monolayers presenting different surface chemistries. Acta Biomater 2010;6:12-20.
57. Benoit DS, Durney AR, Anseth KS. The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation. Biomaterials 2007;28:66-77. (Pubitemid 44427907)
58. Benoit DS, Collins SD, Anseth KS. Multifunctional hydrogels that promote osteogenic hMSC differentiation through stimulation and sequestering of BMP2. Adv Funct Mater 2007;17:2085-93. (Pubitemid 47396193)
59. Canalis E. Skeletal growth factors. Philadelphia, PA: Lippincott Williams & Wilkins; 2000. p. 480.